Société Relmada Therapeutics, Inc. OTC Markets
Actions
RLMD
US75955J4022
Recherche biotechnologique et médicale
Temps réel estimé
Autres places de cotation
|
Varia. 5j. | Varia. 1 janv. | ||
3,67 USD | 0,00% |
|
+8,91% | +139,13% |
Métier
Dirigeants
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Paolo Manfredi
FOU | Founder | 62 | 31/05/12 |
Sergio Traversa
CEO | Chief Executive Officer | 63 | - |
Maged Shenouda
DFI | Director of Finance/CFO | 59 | 12/11/15 |
Charles Ence
CMP | Compliance Officer | 64 | 29/07/19 |
John Hixon
PRN | Corporate Officer/Principal | - | 21/07/22 |
Administrateurs
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Chairman | 78 | 14/07/15 | |
Sergio Traversa
CEO | Chief Executive Officer | 63 | - |
Maged Shenouda
DFI | Director of Finance/CFO | 59 | 12/11/15 |
Fabiana Fedeli
BRD | Director/Board Member | 53 | 12/01/23 |
Director/Board Member | 61 | 19/12/19 | |
Paul Kelly
BRD | Director/Board Member | 65 | 12/11/15 |
Classe d'actions
Vote | Nombre | Flottant | Autocontrôle | Flottant Total | |
---|---|---|---|---|---|
Action A | 1 | 30 174 202 | 27 748 959 ( 91,96 %) | 0 | 91,96 % |
Coordonnées société
Relmada Therapeutics, Inc.
2222 Ponce de Leon Boulevard 3rd floor
33134, Coral Gables
+786-629-1376
http://www.relmada.com![Adresse Relmada Therapeutics, Inc.(RLMD)](https://cdn.zonebourse.com/static/address/23400702.png)
Secteur
![Consensus](/images/consensus_flch.gif)
Révisions de BNA
Varia. 1 janv. | Capi. | |
---|---|---|
+19,22% | 126 Md | |
+22,79% | 118 Md | |
+23,26% | 27,87 Md | |
-19,35% | 20,95 Md | |
-15,13% | 16,92 Md | |
-14,52% | 16,18 Md | |
+9,51% | 14,84 Md | |
-46,10% | 14,79 Md | |
+50,47% | 14,08 Md |
- Bourse
- Actions
- Action RLMD
- Action RLMD
- Société Relmada Therapeutics, Inc.